- Home
- MGTX vs AXGN Comparison
MGTX vs AXGN Comparison
Compare MGTX & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGTX
- AXGN
- Stock Information
- Founded
- MGTX 2015
- AXGN N/A
- Country
- MGTX United States
- AXGN United States
- Employees
- MGTX N/A
- AXGN N/A
- Industry
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MGTX Health Care
- AXGN Health Care
- Exchange
- MGTX Nasdaq
- AXGN Nasdaq
- Market Cap
- MGTX 670.2M
- AXGN 577.0M
- IPO Year
- MGTX N/A
- AXGN N/A
- Fundamental
- Price
- MGTX $7.29
- AXGN $16.14
- Analyst Decision
- MGTX Strong Buy
- AXGN Strong Buy
- Analyst Count
- MGTX 2
- AXGN 5
- Target Price
- MGTX $24.00
- AXGN $26.00
- AVG Volume (30 Days)
- MGTX 321.7K
- AXGN 1.7M
- Earning Date
- MGTX 08-14-2025
- AXGN 08-05-2025
- Dividend Yield
- MGTX N/A
- AXGN N/A
- EPS Growth
- MGTX N/A
- AXGN N/A
- EPS
- MGTX N/A
- AXGN N/A
- Revenue
- MGTX $37,917,000.00
- AXGN $203,271,000.00
- Revenue This Year
- MGTX $145.67
- AXGN $19.65
- Revenue Next Year
- MGTX $167.61
- AXGN $15.84
- P/E Ratio
- MGTX N/A
- AXGN N/A
- Revenue Growth
- MGTX 366.84
- AXGN 17.17
- 52 Week Low
- MGTX $3.85
- AXGN $9.22
- 52 Week High
- MGTX $8.98
- AXGN $21.00
- Technical
- Relative Strength Index (RSI)
- MGTX 41.87
- AXGN 65.49
- Support Level
- MGTX $7.34
- AXGN $13.64
- Resistance Level
- MGTX $7.75
- AXGN $16.54
- Average True Range (ATR)
- MGTX 0.40
- AXGN 0.72
- MACD
- MGTX -0.07
- AXGN 0.03
- Stochastic Oscillator
- MGTX 7.78
- AXGN 86.21
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.